Case report: Spurious hypokalemia in myeloproliferative disordersNAPARSTEK, Y; GUTMAN, A.The American journal of the medical sciences. 1984, Vol 288, Num 4, pp 175-177, issn 0002-9629Article

Acquired von Willebrand's disease in the myeloproliferative syndromeBUDDE, U; SCHAEFER, G; MUELLER, N et al.Blood. 1984, Vol 64, Num 5, pp 981-985, issn 0006-4971Article

Myeloproliferative disordersMURRAY, Jim.Clinical medicine. 2005, Vol 5, Num 4, pp 328-332, issn 1470-2118, 5 p.Article

Patterns of T cell subset alterations in myelo- and lymphoproliferative disordersFIORINI, G; GENIRAM, A; FREZZINI, G et al.Blut. 1984, Vol 48, Num 5, pp 321-325, issn 0006-5242Article

Simultaneous study of platelets and phagocytes in myeloproliferative disordersLAHARRAGUE, P. F; CORBERAND, J. X; FILLOLA, G et al.Biomedicine & pharmacotherapy. 1984, Vol 38, Num 9-10, pp 462-465, issn 0753-3322Article

Studies of the platelet density abnormality in myeloproliferative diseaseHOLME, S; MURPHY, S.The Journal of laboratory and clinical medicine. 1984, Vol 103, Num 3, pp 373-383, issn 0022-2143Article

Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with timeBAKER, R. I; MANOHARAN, A.European journal of haematology. 1988, Vol 40, Num 3, pp 267-272, issn 0902-4441Article

UNCONTROLLED THROMBOCYTOSIS IN CHRONIC MYELOPROLIFERATIVE DISORDERSKESSLER CM; KLEIN HG; HAVLIK RJ et al.1982; BR. J. HAEMATOL.; ISSN 0007-1048; GBR; DA. 1982; VOL. 50; NO 1; PP. 157-167; BIBL. 2 P.Article

MALIGNANT MYELOPROLIFERATIVE DISORDER1978; AMER. J. MED.; USA; DA. 1978; VOL. 65; NO 2; PP. 315-324; BIBL. 19 REF.Article

Transient myeloproliferative disorderMOIZ, Bushra; SHAFLQ, Maria.Blood. 2012, Vol 120, Num 24, issn 0006-4971, p. 4672Article

Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative diseaseAGARWAL, Anupriya; BUMM, Thomas G. P; DEININGER, Michael W et al.Blood. 2008, Vol 112, Num 5, pp 1960-1970, issn 0006-4971, 11 p.Article

Genetics of myeloid malignancies : Pathogenetic and clinical implicationsFROHLING, Stefan; SCHOLL, Claudia; GILILAND, D. Gary et al.Journal of clinical oncology. 2005, Vol 23, Num 26, pp 6285-6295, issn 0732-183X, 11 p.Article

Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disordersMALPASS, T. W; SAVAGE, B; HANSON, S. R et al.The Journal of laboratory and clinical medicine. 1984, Vol 103, Num 6, pp 894-904, issn 0022-2143Article

Myeloproliferative disease in two young siblings = Syndrome myéloprolifératif chez deux jeunes frère et sœurCERVANTES, F; RIBERA, J.-M; SANCHEZ-BISONO, J et al.Cancer. 1984, Vol 54, Num 5, pp 899-902, issn 0008-543XArticle

Clinical features and molecular analysis of acquired hemoglobin H diseaseHIGGS, D. R; WOOD, W. G; BARTON, C et al.The American journal of medicine. 1983, Vol 75, Num 2, pp 181-191, issn 0002-9343Article

Differences among myeloproliferative disorders in the behavior of their restricted progenitor cells in culture = Différences de comportement des cellules précurseurs en culture des diverses affections myéloproliférativesCROIZAT, H; AMATO, D; MCLEOD, D. L et al.Blood. 1983, Vol 62, Num 3, pp 578-584, issn 0006-4971Article

Myeloproliferative neoplasmsPUBLICOVER, Amy; MEDD, Patrick.Clinical medicine. 2013, Vol 13, Num 2, pp 188-192, issn 1470-2118, 5 p.Article

Syndromes myéloprolifératifs Philadelphie-négatifsKILADJIAN, Jean-Jacques.Hématologie (Montrouge). 2007, Vol 13, pp 55-58, issn 1264-7527, 4 p., NS1Conference Paper

Some aspects of platelet glucose metabolism in thrombocytosis due to myeloproliferative disordersLEONCINI, G; MARESCA, M; BALESTRERO, F et al.Thrombosis research. 1984, Vol 34, Num 3, pp 233-239, issn 0049-3848Article

Arguments en faveur d'un rôle physiopathogénique de la lignée mégacaryocyto-plaquettaire = Arguing for a pathogenic relationship of the megacaryocyte-thrombocytic cell lineDROUET, L.Actualités hématologiques. 1983, Vol 17, pp 80-88, issn 0567-8757Article

Mini Symposium sur les Syndromes MyéloprolifératifsBRIERE, J.Pathologie et biologie. 2001, Vol 49, Num 2, pp 138-183, issn 0369-8114Conference Proceedings

Platelet 5-hydroxytryptamine transport and storage in myeloproliferative disordersCORTELLAZZO, S; VIERO, P; BUCZKO, W et al.Scandinavian journal of haematology. 1985, Vol 34, Num 2, pp 146-151, issn 0036-553XArticle

Syndrome hyperéosinophilique: un nouveau cas à forme myéloproliférative = Hypereosinophilic syndrome ― A new case of myeloproliferative typeMARECHAUD, R; NEAU, J. P; QUERON, B et al.La Revue de médecine interne (Paris). 1985, Vol 6, Num 2, pp 155-157, issn 0248-8663Article

Increased erythrocyte susceptibility to lipid peroxidation in myeloproliferative disordersGILBERT, H. S; ROTH, E. F. JR; GINSBERG, H et al.The Journal of laboratory and clinical medicine. 1984, Vol 103, Num 1, pp 6-13, issn 0022-2143Article

Role of Additional Novel Therapies in Myeloproliferative NeoplasmsFISKUS, Warren; GANGULY, Siddhartha; KAMBHAMPATI, Suman et al.Hematology/oncology clinics of North America. 2012, Vol 26, Num 5, issn 0889-8588, vii, 959-980 [22 p.]Article